419 related articles for article (PubMed ID: 16099624)
61. Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitis.
Brandt CT; Frimodt-Møller N; Lundgren JD; Pedersen M; Skovsted IC; Rowland IJ; Østergaard C
J Antimicrob Chemother; 2006 Dec; 58(6):1291-4. PubMed ID: 17068007
[TBL] [Abstract][Full Text] [Related]
62. Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing.
Croisier-Bertin D; Piroth L; Charles PE; Larribeau A; Biek D; Ge Y; Chavanet P
Antimicrob Agents Chemother; 2011 Jul; 55(7):3557-63. PubMed ID: 21576444
[TBL] [Abstract][Full Text] [Related]
63. Infective endocarditis caused by Streptococcus pneumoniae with high-level resistance to penicillin and cephalosporin.
Whitby S; Pallera A; Schaberg DR; Bronze MS
Clin Infect Dis; 1996 Nov; 23(5):1176-7. PubMed ID: 8922823
[No Abstract] [Full Text] [Related]
64. Vancomycin Should Be Part of Empiric Therapy for Suspected Bacterial Meningitis.
Olarte L
J Pediatric Infect Dis Soc; 2019 May; 8(2):187-188. PubMed ID: 30496558
[TBL] [Abstract][Full Text] [Related]
65. Emergence of vancomycin tolerance in Streptococcus pneumoniae.
Novak R; Henriques B; Charpentier E; Normark S; Tuomanen E
Nature; 1999 Jun; 399(6736):590-3. PubMed ID: 10376600
[TBL] [Abstract][Full Text] [Related]
66. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
Gerber P; Stucki A; Acosta F; Cottagnoud M; Cottagnoud P
J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
[TBL] [Abstract][Full Text] [Related]
67. Meningitis due to ceftriaxone-resistant Streptococcus pneumoniae.
Lonks JR; Durkin MR; Meyerhoff AN; Medeiros AA
N Engl J Med; 1995 Mar; 332(13):893-4. PubMed ID: 7870156
[No Abstract] [Full Text] [Related]
68. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
[TBL] [Abstract][Full Text] [Related]
69. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Ahmed A; Jafri H; Lutsar I; McCoig CC; Trujillo M; Wubbel L; Shelton S; McCracken GH
Antimicrob Agents Chemother; 1999 Apr; 43(4):876-81. PubMed ID: 10103194
[TBL] [Abstract][Full Text] [Related]
70. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
París MM; Hickey SM; Trujillo M; Shelton S; McCracken GH
Antimicrob Agents Chemother; 1995 Jun; 39(6):1243-6. PubMed ID: 7574509
[TBL] [Abstract][Full Text] [Related]
71. Antimicrobial sensitivity pattern, demographic findings and risk factors amongst meningitis and non-meningitis invasive Streptococcus pneumoniae at Aga Khan University Hospital Clinical Laboratory, Karachi, Pakistan.
Irfan S; Farooqi J; Kumar H; Zafar A
J Pak Med Assoc; 2019 Aug; 69(8):1124-1130. PubMed ID: 31431765
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
[TBL] [Abstract][Full Text] [Related]
73. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
[No Abstract] [Full Text] [Related]
74. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
Goldwater PN
Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
[TBL] [Abstract][Full Text] [Related]
75. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
Rodoni D; Hänni F; Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
Antimicrob Agents Chemother; 1999 Apr; 43(4):963-5. PubMed ID: 10103211
[TBL] [Abstract][Full Text] [Related]
76. [Therapeutic impact of changing susceptibility of germs causing community-acquired bacterial meningitis in pediatric patients (excluding neonatal period)].
Doit C; Bingen E
Ann Med Interne (Paris); 2002 Sep; 153(5):329-37. PubMed ID: 12442079
[No Abstract] [Full Text] [Related]
77. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
[TBL] [Abstract][Full Text] [Related]
78. Efficacy of ceftaroline fosamil against penicillin-sensitive and -resistant streptococcus pneumoniae in an experimental rabbit meningitis model.
Cottagnoud P; Cottagnoud M; Acosta F; Stucki A
Antimicrob Agents Chemother; 2013 Oct; 57(10):4653-5. PubMed ID: 23836180
[TBL] [Abstract][Full Text] [Related]
79. Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: case series and review of the literature.
Plakogiannis R; Nogid A
Pharmacotherapy; 2007 Oct; 27(10):1456-61. PubMed ID: 17896901
[TBL] [Abstract][Full Text] [Related]
80. Antimicrobial susceptibility patterns of Haemophilus influenzae and Streptococcus pneumoniae isolates in a Beirut general university hospital between 2000 and 2004.
Daoud Z; Cocozaki A; Hakime N
Clin Microbiol Infect; 2006 Jan; 12(1):86-90. PubMed ID: 16460553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
